Video Latest - ecancer

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK

3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

3 Dec 2013

The immune microenvironment as an anti-cancer therapeutic strategy

Dr Lisa Coussens - Oregon Science & Health University, USA

12 Nov 2013

The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary

Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada

8 Nov 2013

European Cancer Congress 2013 - News Roundup

Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology

22 Oct 2013

Meeting highlights from the 11th iwNHL 2013: Day 2

Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh

15 Oct 2013

Survival analysis of a follow-up phase III study of ipilimumab and dacarbazine in metastatic melanoma

Dr Michele Maio - University Hospital of Siena, Siena, Italy

4 Oct 2013

Analysis of progression free survival versus overall survival in melanoma

Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA

3 Oct 2013

New antibody drug, MPDL3280A, in non-small cell lung cancer

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France

3 Oct 2013

Meta-analysis of ipilimumab in metastatic or locally advanced, unresectable melanoma

Prof Dirk Schadendorf - Universitätsklinikum Essen, Essen, Germany

3 Oct 2013

Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy

29 Sep 2013

Results for new antibody drug in non-small cell lung cancer

Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France

29 Sep 2013

Video